Lung Therapeutics: Aileron Therapeutics Acquires Lung Therapeutics

Aileron Therapeutics, Inc. (NASDAQ: ALRN) acquired Lung Therapeutics, Inc., an Austin, Texas-based biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications that have no approved or limited effective treatments. Immediately following the acquisition of Lung Tx, Aileron entered into a definitive agreement for the sale of shares of Aileron's [...]The post Aileron Therapeutics Acquires Lung Therapeutics appeared first on FinSMEs.